Items where Author is "Butterfield, LH"
Group by: Item Type | No Grouping Jump to: Article Number of items: 19. ArticleRetseck, J and VanderWeele, R and Lin, HM and Lin, Y and Butterfield, LH and Tarhini, AA (2016) Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab. Journal for ImmunoTherapy of Cancer, 4 (1). Kaufman, HL and Butterfield, LH and Coulie, PG and Demaria, S and Ferris, RL and Galon, J and Khleif, SN and Mellman, I and Ohashi, PS and Overwijk, WW and Topalian, SL and Marincola, FM (2016) Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule. Journal for ImmunoTherapy of Cancer, 4 (1). Radomski, M and Zeh, HJ and Edington, HD and Pingpank, JF and Butterfield, LH and Whiteside, TL and Wieckowski, E and Bartlett, DL and Kalinski, P (2016) Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer. Journal for ImmunoTherapy of Cancer, 4 (1). Steel, JL and Geller, DA and Kim, Kevin H and Butterfield, LH and Spring, Michael and Grady, Jonathan and Sun, W and Marsh, W and Antoni, M and Dew, MA and Helgeson, V and Schulz, Richard and Tsung, A (2016) Web-based collaborative care intervention to manage cancer-related symptoms in the palliative care setting. Cancer, 122 (8). 1270 - 1282. ISSN 0008-543X Yuan, J and Hegde, PS and Clynes, R and Foukas, PG and Harari, A and Kleen, TO and Kvistborg, P and Maccalli, C and Maecker, HT and Page, DB and Robins, H and Song, W and Stack, EC and Wang, E and Whiteside, TL and Zhao, Y and Zwierzina, H and Butterfield, LH and Fox, BA (2016) Novel technologies and emerging biomarkers for personalized cancer immunotherapy. Journal for ImmunoTherapy of Cancer, 4 (1). Tarhini, AA and Zahoor, H and Lin, Y and Malhotra, U and Sander, C and Butterfield, LH and Kirkwood, JM (2015) Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma. Journal for ImmunoTherapy of Cancer, 3 (1). Pardee, AD and Yano, H and Weinstein, AM and Ponce, AAK and Ethridge, AD and Normolle, DP and Vujanovic, L and Mizejewski, GJ and Watkins, SC and Butterfield, LH (2015) Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer, 3 (1). Tarhini, AA and Lin, Y and Zahoor, H and Shuai, Y and Butterfield, LH and Ringquist, S and Gogas, H and Sander, C and Lee, S and Agarwala, SS and Kirwood, JM (2015) Pro-inflammatory cytokines predict relapse-free survival after one month of interferon-α but not observation in intermediate risk melanoma patients. PLoS ONE, 10 (7). Butterfield, LH and Disis, ML and Fox, BA and Khleif, SN and Marincola, FM (2015) Preamble to the 2015 SITC immunotherapy biomarkers taskforce. Journal for ImmunoTherapy of Cancer, 3 (1). Butterfield, LH and Economou, JS and Gamblin, TC and Geller, DA (2014) Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients. Journal of Translational Medicine, 12 (1). Tarhini, AA and Edington, H and Butterfield, LH and Lin, Y and Shuai, Y and Tawbi, H and Sander, C and Yin, Y and Holtzman, M and Johnson, J and Rao, UNM and Kirkwood, JM (2014) Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab. PLoS ONE, 9 (2). Naveh, HP and Vujanovic, L and Butterfield, LH (2013) Cellular immunity induced by a recombinant adenovirus-human dendritic cell vaccine for melanoma. Journal for ImmunoTherapy of Cancer, 1. Bot, A and Ahn, M and Bosch, M and Brockstedt, D and Butterfield, LH and Cornforth, A and Harrop, R and Kast, WM and Koya, R and Marincola, F and Margolin, K and McCoy, C and Pawelec, G and Rothman, J and Ramirez-Montagut, T and Schlom, J and Srivastava, P and Wallis, S and Walter, S and Wang, E and Waslif, J (2012) A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies. Journal of Translational Medicine, 10 (1). Fox, BA and Schendel, DJ and Butterfield, LH and Aamdal, S and Allison, JP and Ascierto, PA and Atkins, MB and Bartunkova, J and Bergmann, L and Berinstein, N and Bonorino, CC and Borden, E and Bramson, JL and Britten, CM and Cao, X and Carson, WE and Chang, AE and Characiejus, D and Raja Choudhury, A and Coukos, G and de Gruijl, T and Dillman, RO and Dolstra, H and Dranoff, G and Durrant, LG and Finke, JH and Galon, J and Gollob, JA and Gouttefangeas, C and Grizzi, F and Guida, M and Håkansson, L and Hege, K and Herberman, RB and Stephen Hodi, F and Hoos, A and Huber, C and Hwu, P and Imai, K and Jaffee, EM and Janetzki, S and June, CH and Kalinski, P and Kaufman, HL and Kawakami, K and Kawakami, Y and Keilholtz, U and Khleif, SN and Kiessling, R and Kotlan, B and Kroemer, G and Lapointe, R and Levitsky, HI and Lotze, MT and Maccalli, C and Maio, M and Marschner, JP and Mastrangelo, MJ and Masucci, G and Melero, I and Melief, C and Murphy, WJ and Nelson, B and Nicolini, A and Nishimura, MI and Odunsi, K and Ohashi, PS and O'Donnell-Tormey, J and Old, LJ and Ottensmeier, C and Papamichail, M and Parmiani, G and Pawelec, G and Proietti, E and Qin, S and Rees, R and Ribas, A and Ridolfi, R and Ritter, G and Rivoltini, L and Romero, PJ and Salem, ML and Scheper, RJ and Seliger, B and Sharma, P and Shiku, H and Singh-Jasuja, H and Song, W and Straten, PT and Tahara, H and Tian, Z and van der Burg, SH and von Hoegen, P and Wang, E and Welters, MJP and Winter, H and Withington, T and Wolchok, JD and Xiao, W and Zitvogel, L (2011) Defining the critical hurdles in cancer immunotherapy. Journal of Translational Medicine, 9 (1). Bedognetti, D and Balwit, JM and Wang, E and Disis, ML and Britten, CM and Delogu, LG and Tomei, S and Fox, BA and Gajewski, TF and Marincola, FM and Butterfield, LH (2011) SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery. Journal of Translational Medicine, 9 (1). Butterfield, LH and Potter, DM and Kirkwood, JM (2011) Multiplex serum biomarker assessments: technical and biostatistical issues. Journal of translational medicine, 9. 173 - ?. Butterfield, LH and Disis, ML and Khleif, SN and Balwit, JM and Marincola, FM (2010) Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force. Journal of Translational Medicine, 8. John, E and Laskow, TC and Buchser, WJ and Pitt, BR and Basse, PH and Butterfield, LH and Kalinski, P and Lotze, MT (2010) Zinc in innate and adaptive tumor immunity. Journal of Translational Medicine, 8. Okada, H and Lieberman, FS and Walter, KA and Lunsford, LD and Kondziolka, DS and Bejjani, GK and Hamilton, RL and Torres-Trejo, A and Kalinski, P and Cai, Q and Mabold, JL and Edington, HD and Butterfield, LH and Whiteside, TL and Potter, DM and Schold, SC and Pollack, IF (2007) Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas. Journal of Translational Medicine, 5. |